← Evidence map

ArticleBlood2023

Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies.

James A Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

33 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36332185